{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T14:07:55Z","timestamp":1773410875112,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.neuropharm.2006.08.018","type":"journal-article","created":{"date-parts":[[2006,11,21]],"date-time":"2006-11-21T19:53:40Z","timestamp":1164138820000},"page":"515-526","source":"Crossref","is-referenced-by-count":15,"title":["Tamoxifen effect on L-DOPA induced response complications in parkinsonian rats and primates"],"prefix":"10.1016","volume":"52","author":[{"given":"C.P.S.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.D.","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bibbiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Avila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.N.","family":"Chase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2006.08.018_bib1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0928-0987(99)00017-2","article-title":"Alterations of second messenger systems in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle","volume":"8","author":"Araki","year":"1999","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib2","first-page":"461","article-title":"Tamoxifen and vitamin E treatments delay symptoms in the mouse model of Niemann-Pick C","volume":"45","author":"Bascunan-Castillo","year":"2004","journal-title":"Journal of Applied Genetics"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib3","doi-asserted-by":"crossref","first-page":"27662","DOI":"10.1074\/jbc.M502593200","article-title":"\u03bc and \u03ba opioid receptors activate ERK\/MAPK via different protein kinase C isoforms and secondary messengers in astrocytes","volume":"280","author":"Blecheva","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib4","first-page":"376","article-title":"5HT2A antagonist improves levodopa-induced dyskinesias in MPTP lesioned cynomolgus monkeys","volume":"56","author":"Bibbiani","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib5","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S0022-3565(24)35003-7","article-title":"Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys","volume":"290","author":"Blanchet","year":"1999","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib6","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1523\/JNEUROSCI.15-07-05372.1995","article-title":"Elevated body swing test: a new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism","volume":"15","author":"Borlongan","year":"1995","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib7","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/S1471-1931(00)00026-4","article-title":"Dopamine-receptor stimulation: biobehavioral and biochemical consequences","volume":"23","author":"Calon","year":"2000","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0278-5846(97)00011-0","article-title":"Intracellular signal modulation: a pivotal role for protein kinase C","volume":"21","author":"Casabona","year":"1997","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib9","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/13803390490510905","article-title":"Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen","volume":"26","author":"Castellon","year":"2004","journal-title":"Journal of Clinical and Experimental Neuropsychology"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib10","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1212\/WNL.50.5_Suppl_5.S17","article-title":"Levodopa therapy: consequences of the non-physiological replacement of dopamine","volume":"50","author":"Chase","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib11","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/S1471-1931(00)00018-5","article-title":"Striatal dopamine and glutamate mediated dysregulation in experimental parkinsonism","volume":"23","author":"Chase","year":"2000","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/PL00007759","article-title":"Antiparkinsonian and antidyskinetic activity of drugs targeting central glutamatergic mechanisms","volume":"247","author":"Chase","year":"2000","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib13","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.2042-7158.1998.tb03363.x","article-title":"Effects of tamoxifen on striatal dopamine and 5-hydroxytryptamine release in freely moving male rats: an in-vivo microdialysis investigation","volume":"50","author":"Chaurasia","year":"1998","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neuroscience.2004.10.026","article-title":"Enhanced striatal opioid receptor mediated G-protein activation in L-dopa-treated dyskinetic monkeys","volume":"132","author":"Chen","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1471-4159.2005.03545.x","article-title":"Conventional protein kinase C isoforms mediate neuroprotection induced by phorbol ester and estrogen","volume":"96","author":"Cordey","year":"2006","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/jnr.20412","article-title":"Regulation of striatal preproenkephalin mRNA levels in MPTP-lesioned mice treated with estradiol","volume":"80","author":"D'Astous","year":"2005","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1023\/A:1007117424491","article-title":"Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system","volume":"29","author":"Dluzen","year":"2000","journal-title":"Journal of Neurocytology"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/exnr.2001.7698","article-title":"Evaluation of nigrostriatal dopaminergic function in adult +\/+ and +\/\u2212 BDNF mutant mice","volume":"170","author":"Dluzen","year":"2001","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pbb.2004.10.007","article-title":"Gender differences in modulatory effects of tamoxifen upon the nigrostriatal dopaminergic system","volume":"80","author":"Dluzen","year":"2005","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neuroimage.2003.08.037","article-title":"Estrogen- and tamoxifen-associated effects on brain structure and function","volume":"21","author":"Eberling","year":"2004","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.molbrainres.2003.08.002","article-title":"Protein kinases regulate the phosphorlyation of the GluR1 subunit of AMPA receptors of spinal cord in rats following noxious stimulation","volume":"118","author":"Fang","year":"2003","journal-title":"Brain Research"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib22","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1091\/mbc.E05-02-0134","article-title":"Association of an A-kinase-anchoring protein signaling scaffold with cadherin adhesion molecules in neurons and epithelial cells","volume":"16","author":"Gorski","year":"2005","journal-title":"Molecular Biology of the Cell"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/exnr.1998.6996","article-title":"Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat","volume":"155","author":"Henry","year":"1999","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jsbmb.2004.12.002","article-title":"Steroid hormone receptors as targets for the therapy of breast and prostate cancer \u2013 recent advances, mechanisms of resistance, and new approaches","volume":"93","author":"Hoffmann","year":"2005","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib25","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1212\/WNL.51.2_Suppl_2.S2","article-title":"Biochemical aspects of Parkinson's disease","volume":"51","author":"Hornykiewicz","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.brainres.2005.08.031","article-title":"Activation of protein kinase C and inositol 1,4,5-triphosphate receptors antagonistically modulate voltage-gated sodium channels in striatal neurons","volume":"1059","author":"Hourez","year":"2005","journal-title":"Brain Research"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib27","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00204-002-0420-0","article-title":"The anti-breast cancer drug tamoxifen alters Ca2+ movement in Chinese hamster ovary (CHO-K1) cells","volume":"160","author":"Jan","year":"2003","journal-title":"Archives of Toxicology"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/pon.709","article-title":"Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study","volume":"13","author":"Jenkins","year":"2004","journal-title":"Psychooncology"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib29","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1212\/WNL.61.6_suppl_3.S4","article-title":"The MPTP-treated primate as a model of motor complications in PD: primate model of motor complications","volume":"61","author":"Jenner","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib30","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1471-4159.2005.03424.x","article-title":"Suppression of protein kinase C mediates 17b-estradiol-induced neuroprotection in an immortalized hippocampal cell line","volume":"95","author":"Jung","year":"2005","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib31","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1093\/emboj\/17.14.4046","article-title":"Transcriptional activation of c-fos by oncogenic Ha-Ras in mouse mammary epithelial cells requires the combined activities of PKC-lambda, epsilon and zeta","volume":"17","author":"Kampfer","year":"1998","journal-title":"EMBO Journal"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3940(01)01515-4","article-title":"Identification of protein kinase C isoforms involved in interferon-gamma-induced expression of inducible nitric oxide synthase in murine BV2 microglia","volume":"299","author":"Kang","year":"2001","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib33","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1126\/science.1082609","article-title":"Asymmetrical allocation of NMDA receptor epsilon 2 subunits in hippocampal circuitry","volume":"300","author":"Kawakami","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib34","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0039-128X(98)00095-6","article-title":"Rapid effects of estrogen to modulate G protein-coupled receptors via activation of protein kinase A and protein kinase C pathways","volume":"64","author":"Kelly","year":"1999","journal-title":"Steroids"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib35","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.54.8.1589","article-title":"AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys","volume":"54","author":"Konitsiotis","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib36","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/jcp.20674","article-title":"Dopamine regulates cell cycle regulatory proteins via cAMP, Ca (2+)\/PKC, MAPKs, and NF-kappaB in mouse embryonic stem cells","volume":"208","author":"Lee","year":"2006","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1034\/j.1600-0773.2002.910106.x","article-title":"Effect of the anti-breast cancer drug tamoxifen on Ca(2+) movement in human osteosarcoma cells","volume":"91","author":"Lu","year":"2002","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/(SICI)1098-2396(20000615)36:4<267::AID-SYN3>3.0.CO;2-Y","article-title":"Non-NMDA receptor mediated mechanisms are involved in levodopa-induced motor response alterations in Parkinsonian rats","volume":"36","author":"Marin","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/bj3320281","article-title":"The extended protein kinase C superfamily","volume":"332","author":"Mellor","year":"1998","journal-title":"Journal of Biochemistry"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib41","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1212\/WNL.51.2.649-a","article-title":"Suprathreshold levodopa doses, dyskinesias, and disability in advanced Parkinson's disease \u2013 Reply","volume":"51","author":"Metman","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib42","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00002826-199712000-00004","article-title":"Motor complications of chronic levodopa therapy in Parkinson's disease","volume":"20","author":"Miyawaki","year":"1997","journal-title":"Clinical Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib43","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/jcp.20033","article-title":"Differential signaling of purinoceptors in HeLa cells through the extracellular signal-regulated kinase and protein kinase C pathways","volume":"200","author":"Muscella","year":"2004","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.neulet.2005.12.077","article-title":"L-DOPA treatment of parkinsonian rats changes the expression of Src, Lyn and PKC kinases","volume":"398","author":"Napolitano","year":"2006","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib45","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neulet.2005.12.040","article-title":"Activation of protein kinase C enhances 1-methyl-4-phenylpyridinium ion (MPP+)-induced hydroxyl radical generation in rat striatum","volume":"398","author":"Obata","year":"2006","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib46","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3940(01)01966-8","article-title":"Protective effects of tamoxifen on 1-methly-4-phenylpyridine-induced hydroxyl radical generation in the rat striatum","volume":"308","author":"Obata","year":"2001","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib47","first-page":"2462","article-title":"Inhibition of protein kinase C by tamoxifen","volume":"45","author":"O'Brian","year":"1985","journal-title":"Cancer Research"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib48","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0006-8993(98)01049-X","article-title":"Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and L-DOPA administration","volume":"813","author":"Oh","year":"1998","journal-title":"Brain Research"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib49","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0006-8993(03)02348-5","article-title":"Gene transfer of constitutively active protein kinase C into striatal neurons accelerates onset of levodopa-induced motor response alterations in parkinsonian rats","volume":"971","author":"Oh","year":"2003","journal-title":"Brain Research"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib50","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.expneurol.2004.01.014","article-title":"Impact of the selective estrogen receptor modulator, tamoxifen, on neural outgrowth and survival following toxic insults associated with aging and Alzheimer's disease","volume":"188","author":"O'Neill","year":"2004","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(93)90446-T","article-title":"Metabolic receptor stimulation coupled to weak tetanus leads to long-term potentiation and a rapid elevation of cytosolic protein kinase C activity","volume":"613","author":"Otani","year":"1993","journal-title":"Brain Research"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib52","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0006-8993(94)90796-X","article-title":"Motor fluctuations in levodopa treated parkinsonian rats \u2013 relation to lesion extent and treatment duration","volume":"662","author":"Papa","year":"1994","journal-title":"Brain Research"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib53","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1212\/WNL.51.2_Suppl_2.S25","article-title":"Classification of fluctuations in patients with Parkinson's disease","volume":"51","author":"Quinn","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib54","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.expneurol.2003.09.001","article-title":"Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia","volume":"185","author":"Ravenscroft","year":"2004","journal-title":"Exploratory Neurology"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-4731(82)90137-6","article-title":"Tamoxifen antiestrogens. A comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans isomers of tamoxifen","volume":"16","author":"Robertson","year":"1982","journal-title":"Journal of Steroid Biochemistry"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib56","article-title":"Enhanced striatal PKC lambda contributes to the development of levodopa-induced motor response alterations in hemiparkinsonian rats","volume":"734.4","author":"Smith","year":"2003","journal-title":"Society of Neuroscience Abstracts"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib57","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0169-328X(98)00157-0","article-title":"NMDA receptor subunits in the postsynaptic density of rat brain: expression and phosphorylation by endogenous protein kinases","volume":"59","author":"Suen","year":"1998","journal-title":"Molecular Brain Research"},{"key":"10.1016\/j.neuropharm.2006.08.018_bib59","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1046\/j.1460-9568.2000.00988.x","article-title":"Alterations in preproenkephalin and adenosine-2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with l-DOPA","volume":"12","author":"Zeng","year":"2000","journal-title":"European Journal of Neuroscience"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390806002929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390806002929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T01:05:51Z","timestamp":1736643951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390806002929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0028390806002929"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2006.08.018","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}